Receptor Reexpression after Hypermethylation: Novel Targets for Inhibitors and Antibody-Drug Conjugates in ALL
Abstract
Despite improved overall prognosis, the treatment of high-risk acute lymphoblastic leukemia (ALL) remains challenging due to the toxicity of intensive polychemotherapy and the limited efficacy of antibody-targeted therapies b... | Find, read and cite all the research you need on Tech Science Press
Fields of Study & Subjects
Acute Lymphoblastic Leukemia research
CAR-T cell therapy research
Chronic Myeloid Leukemia Treatments
Publication details
- Journal / source
- Biocell
- Publisher
- Tech Science Press
- Volume
- 50
- Issue
- 5
- Pages
- 1–10
- Publication date
- 1 January 2026
- Language
- EN